Simulations Plus announces strategic collaboration to advance AI modelling in pharma
The collaboration will also serve as a foundation for broader enterprise adoption, hgelping to define how AI-enabled capabilities are deployed
Credit: gorodenkoff-shutterstock
Participating companies will integrate the Company’s internally developed AI agents directly into model-informed drug development (MIDD) workflows
Register for FREE to keep reading
Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with:
- Insights into HPC, AI, lab informatics & data
- Curated content for life sciences, engineering & academia
- Access to Breakthroughs: real-world computing success
- Free reports & panels, including the Lab Informatics Guide
- White Papers & software updates for smarter research
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
